Clinical Trials Directory

Trials / Completed

CompletedNCT01677481

Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial

Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial.

Status
Completed
Phase
Study type
Observational
Enrollment
1,500 (actual)
Sponsor
Total Cardiovascular Solutions · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The study compares radiation exposure parameters between coronary angiography procedures performed by left wrist, right wrist or groin (femoral) procedure access site

Detailed description

Patients referred for coronary angiography will be randomized to either left radial, right radial or femoral arterial access sites, and the coronary angiogram will be performed in a standard fashion, including left ventriculography. Radiation exposure parameters including Air Kerma, Dose-area product, Fluoroscopy time and Operator radiation exposure will be recorded. Operator experience as well as demographic data will be recorded.

Conditions

Timeline

Start date
2011-02-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2012-09-03
Last updated
2016-03-15

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01677481. Inclusion in this directory is not an endorsement.

Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial (NCT01677481) · Clinical Trials Directory